Video

Kay Verble Discusses a Study to Characterize Long-Term Survivors of GBM

Author(s):

Kay Verble

Kay Verble discusses a research endeavor to characterize long-term survivors of glioblastoma multiforme (GBM).

Kay Verble, from the Sontag Foundation and Brain Tumor Network, discusses a research endeavor to characterize long-term survivors of glioblastoma multiforme (GBM).

Rick Sontag, one of our 2015 GBM Heroes, is an entrepreneur who has worked to improve the lives of patients with GBM and other brain tumors through a multifaceted approach to engaging and supporting the brightest scientific minds in brain cancer research.

Related Videos
Although late-stage kidney cancer generated poor survival rates for over two decades, significant progress is being made in the treatment of the disease.
There are a number of reasons why patients with cancer are encouraged to enroll in clinical trials, Dr. Michael J. Pishvaian explained.
Use of NeuroSAFE to guide nerve sparing during robot-assisted radical prostatectomy improved patient-reported erectile function.
Adolescent and Young Adult Cancer Awareness Week sheds light on the financial hardships young cancer survivors face, including debt and limited assistance.
CURE spoke with Dr. William C. Huang about what kind of team may be required to treat a patient with metastatic kidney cancer.
Image of woman.
Image of woman.
Image of woman.
Image of woman.
Image of man wearing baseball cap backwards.
Related Content
image of dr. Lillian Siu.
April 3rd 2025

Breaking Down Early Signs and Symptoms of Head and Neck Cancer

Dr Lillian Siu
April is Head and Neck Cancer Awareness Month, and it is important to be aware of early signs and symptoms of the disease, as well as when to seek care.
Site Logo
August 29th 2019

Earning Your Legacy: Cancer Has Nothing To Do With It

Kristie L. Kahl
In this episode of the “CURE Talks Cancer” podcast, we spoke with Matt Newman, who was diagnosed with brain cancer at 39, but refuses to let cancer define the legacy he has made.
A new comprehensive hereditary cancer solution offers genetic counseling and multigene panels to enhance early detection of disease's like brain cancer.
April 2nd 2025

A New Comprehensive Hereditary Cancer Solution Has Been Launched

Alex Biese
A new comprehensive hereditary cancer solution offers genetic counseling and multigene panels to enhance early detection of disease's like brain cancer.
Site Logo
April 11th 2019

Addressing Nutritional Needs in Cancer

Kristie L. Kahl
In this week’s episode, we spoke with the founder and CEO of Savor Health on the importance of nutrition for patients and caregivers before, during and after cancer treatment.
CLD-101 treatment showed safety and feasibility in recurrent glioma at multiple intracerebral doses.: © Dr_Microbe - stock.adobe.com
March 26th 2025

Progress Reported in Phase 1 Trial of CLD-101 for Recurrent Glioma

Spencer Feldman
A progress report for a phase 1 trial of CLD-101 in recurrent glioma shows safety and feasibility at multiple intracerebral doses.
Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer
March 6th 2025

Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer

Ryan Scott
Artificial intelligence aids in polyp detection, enhancing colonoscopy effectiveness and reducing the risk of colorectal cancer progression in patients.